LLY
Eli Lilly and Company
LLY has the edge over PARK overall, supported by stronger fundamentals and lower modeled downside.
PARK
Park Dental Partners, Inc. Common Stock
PARK's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
PARK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
PARK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
PARK PE Valuation
PARK has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
PARK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PARK, with profitability improving.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over PARK on earnings quality, reporting a profit while its opponent remains loss making.
PARK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.42 | — |
| Q3 2026 | -$0.95 | -177% |
| Q2 2026 | -$0.91 | -194% |
| Q1 2026 | -$0.52 | -133% |
| Q4 2025 | -$0.06 | -102% |
PARK has swung to a loss: it lost $0.95 per share over the past year, after a profit the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over PARK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over PARK on profitability, with a higher operating margin.
PARK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +6% |
| Q2 2026 | $66.2M | +8.5% |
| Q1 2026 | $62.7M | +2.7% |
| Q4 2025 | $61.2M | +7.5% |
| Q3 2025 | $61.3M | +11% |
| Q2 2025 | $61M | +3.8% |
| Q1 2025 | $61M | +3.8% |
PARK's revenue has grown year over year every quarter since early 2025: $65M last quarter, up 6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.2% | -3.1 points |
| Q2 2026 | 1.9% | -3.6 points |
| Q1 2026 | -3% | -8.5 points |
| Q4 2025 | -13% | +15 points |
| Q3 2025 | 2.9% | +0.6 points |
| Q2 2025 | 5.5% | +0.3 points |
| Q1 2025 | 5.5% | +0.3 points |
| Q4 2024 | -28% | N/A |
PARK's operating margin was −0.2% last quarter, down 3.1 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over PARK on cash flow, with more consistent year-over-year improvement.
PARK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$569K | -110% |
| Q2 2026 | $2.2M | +26% |
| Q1 2026 | $2.7M | -21% |
| Q4 2025 | -$491K | -123% |
| Q3 2025 | $5.6M | -5.6% |
| Q2 2025 | $1.8M | +53% |
| Q1 2025 | $3.4M | +196% |
PARK usually generates cash, though not every quarter: the latest was −$569,000, but it generated $4M over the past year.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
PARK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -27.0x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2,580.6x | Net Cash |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 3.2x | Elevated |
PARK has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
PARK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 32.0 | Neutral |
PARK's weekly RSI is 58 (neutral) and its Stochastic is 32 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
PARK PE vs Healthcare Sector
PARK has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
PARK has stronger trend alignment. LLY is above 5 of 5 weekly averages versus PARK above 3 of 3.
PARK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.1 | 5.3% above |
| 20 week MA | $20.3 | 4.4% above |
| 50 week MA | $18.5 | 15% above |
PARK is in an uptrend: it's above all three of its weekly moving averages, and 15% above its 50-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
PARK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $13.3 | $14.7 | +10% |
| 2026 YTD | $14.7 | $21.2 | +44% |
PARK has the edge over LLY on returns for 2026, with the stronger performance.